Edivoxetine: all 26 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Effect of Clarithromycin on LY2216684CompletedNCT01460407Phase 1Results posted
• A Study to Evaluate the Effect of Genotype on LY2216684CompletedNCT01460381Phase 1Results posted
• A Study to Evaluate the Effect of Food on LY2216684CompletedNCT01389765Phase 1Results posted
• A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy SubjectsCompletedNCT01389752Phase 1Results posted
• A Study of LY2216684 in Healthy ParticipantsCompletedNCT01380691Phase 1Results posted
• A Study of LY2216684 in Healthy FemalesCompletedNCT01373931Phase 1Results posted
• A Study of LY2216684 in Participants With Major Depression DisorderCompletedNCT01370499Phase 3Results posted
• A Study in Prevention of Re-emergence of Depression SymptomsCompletedNCT01299272Phase 3Results posted
• A Study of the Effect of LY2216684 on LorazepamCompletedNCT01275144Phase 1Results posted
• A Study of LY2216684 and Digoxin in Healthy SubjectsCompletedNCT01266590Phase 1Results posted
• A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake InhibitorsCompletedNCT01263223Phase 1Results posted
• A Study of LY2216684 and Warfarin in Healthy SubjectsCompletedNCT01263119Phase 1Results posted
• A Study of LY2216684 and Theophylline in Healthy SubjectsCompletedNCT01263106Phase 1Results posted
• A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of ClopidogrelCompletedNCT01263093Phase 1Results posted
• A Pharmacokinetic Study of the Coadministration of LY2216684 With SertralineCompletedNCT01250873Phase 1Results posted
• A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together.CompletedNCT01243957Phase 1Results posted
• A Study of LY2216684 in Participants With Impaired Hepatic FunctionCompletedNCT01241435Phase 1Results posted
• A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) TreatmentCompletedNCT01187407Phase 3Results posted
• A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake InhibitorCompletedNCT01185340Phase 3Results posted
• A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive DisorderCompletedNCT01173601Phase 3Results posted
• A Safety Study in Participants With Major Depressive DisorderCompletedNCT01155661Phase 3Results posted
• A Study of Pediatric Participants With Attention Deficit/Hyperactivity DisorderTerminatedNCT00965419Phase 2/3Results posted
• A Study of Pediatric Patients With Attention Deficit/Hyperactivity DisorderCompletedNCT00922636Phase 2/3Results posted
• A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive DisorderCompletedNCT00840034Phase 2Results posted
• A Study in Adult Patients With Major Depressive DisorderCompletedNCT00795821Phase 2/3Results posted
• A Study for Participants With Major DepressionCompletedNCT00420004Phase 2Results posted

← Edivoxetine overview